{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:46:55Z","timestamp":1790621215707,"version":"4.1.0"},"reference-count":180,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371271"],"award-info":[{"award-number":["81371271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2018.00153","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T04:17:31Z","timestamp":1526357851000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies"],"prefix":"10.3389","volume":"11","author":[{"given":"Chunchen","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbabio.2015.01.012","article-title":"Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model.","volume":"1847","author":"Ajayi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"P53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease.","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves Cortico-Basal ganglia function in Huntington\u2019s disease models.","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nn.4014","article-title":"A SNP in the HTT promoter alters NF-\u03baB binding and is a bidirectional genetic modifier of Huntington disease.","volume":"18","author":"Be\u010danovi\u0107","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1111\/j.1582-4934.2008.00543.x","article-title":"The polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"13","author":"Bett","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1073\/pnas.1402215111","article-title":"Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.","volume":"15","author":"Bhat","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034805","article-title":"SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington\u2019s disease phenotypes in vivo.","volume":"7","author":"Bobrowska","year":"2012","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JHD-140122","article-title":"Region-specific pro-survival signaling and global neuronal protection by wild-type Huntingtin.","volume":"3","author":"Buren","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"34266","DOI":"10.1074\/jbc.M113.487538","article-title":"Direct inhibition of gcn5 protein catalytic activity by polyglutamine-expanded ataxin-7.","volume":"288","author":"Burke","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E10809","DOI":"10.1073\/pnas.1705372114","article-title":"Phosphorylation of huntingtin at residue T3 is decreased in Huntington\u2019s disease and modulates mutant huntingtin protein conformation.","volume":"50","author":"Cariulo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bpj.2016.06.018","article-title":"Acetylation within the first 17 residues of huntingtin exon 1 alters aggregation and lipid binding.","volume":"111","author":"Chaibva","year":"2016","journal-title":"Biophys. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/hmg\/ddw095","article-title":"Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington\u2019s disease.","volume":"25","author":"Chandra","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1 alpha function in muscle in Huntington\u2019s disease.","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1093\/hmg\/dds178","article-title":"Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington\u2019s disease.","volume":"21","author":"Chaturvedi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-1","article-title":"Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease.","volume":"6","author":"Che","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"B16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/hmg\/ddr474","article-title":"Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.","volume":"21","author":"Chen","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington\u2019s disease.","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington\u2019s disease via activation of the peroxisome proliferator-activated receptor gamma.","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1002\/anie.201611750","article-title":"Mutant exon1 huntingtin aggregation is regulated by T3 phosphorylation-induced structural changes and crosstalk between T3 phosphorylation and acetylation at K6.","volume":"19","author":"Chiki","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nbd.2009.07.014","article-title":"CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington\u2019s disease.","volume":"36","author":"Choi","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3233\/JHD-160226","article-title":"LBH589 a hydroxamic Acid-Derived HDAC inhibitor, is neuroprotective in mouse models of Huntington\u2019s disease.","volume":"5","author":"Chopra","year":"2016","journal-title":"J. Huntingtons Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","article-title":"The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models.","volume":"2","author":"Chopra","year":"2012","journal-title":"Cell Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nbd.2010.10.019","article-title":"HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3.","volume":"41","author":"Chou","year":"","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neuint.2010.11.005","article-title":"P53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.","volume":"58","author":"Chou","year":"","journal-title":"Neurochem. Int."},{"key":"B25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/365855a0","article-title":"Phosphorylated CREB binds specifically to the nuclear protein CBP.","volume":"365","author":"Chrivia","year":"1993","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1172\/JCI73214","article-title":"Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.","volume":"2","author":"Chua","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions.","volume":"11","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/gt.2012.84","article-title":"In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.","volume":"20","author":"Conforti","year":"","journal-title":"Gene Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jnc.12348","article-title":"Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington\u2019s disease models.","volume":"127","author":"Conforti","year":"","journal-title":"J. Neurochem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","article-title":"Mutant huntingtin represses CBP, but not p300 by binding and protein degradation.","volume":"30","author":"Cong","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","article-title":"Toward understanding Machado-Joseph disease.","volume":"2","author":"Costa Mdo","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/hmg\/ddh188","article-title":"Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.","volume":"13","author":"de Pril","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mcn.2006.09.006","article-title":"Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.","volume":"34","author":"de Pril","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.mcn.2009.12.001","article-title":"Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model.","volume":"43","author":"de Pril","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","article-title":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"30","author":"DeMarch","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophicneurites in brain.","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/hmg\/ddw234","article-title":"Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization.","volume":"18","author":"DiGiovanni","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cell.2013.05.059","article-title":"Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6.","volume":"1","author":"Du","year":"2013","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease.","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1523\/JNEUROSCI.2053-06.2006","article-title":"Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3 and histone deacetylation.","volume":"26","author":"Evert","year":"2006","journal-title":"J. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.onc.1209021","article-title":"P53 tumor suppressor protein regulates the levels of huntingtin gene expression.","volume":"25","author":"Feng","year":"2006","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice.","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington\u2019s disease.","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2017.00017","article-title":"Contribution of neuroepigenetics to Huntington\u2019s disease.","volume":"11","author":"Francelle","year":"2017","journal-title":"Front. Hum. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease.","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013417","article-title":"Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington\u2019s disease.","volume":"5","author":"Giampa","year":"2010","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1460-9568.2009.06649.x","article-title":"Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"29","author":"Giampa","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington\u2019s disease mouse model.","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041450","article-title":"Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington\u2019s disease mutation.","volume":"7","author":"Gong","year":"2012","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/hmg\/ddm162","article-title":"Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.","volume":"17","author":"Goold","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17979","DOI":"10.1073\/pnas.1106198108","article-title":"Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin.","volume":"108","author":"Grison","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.","volume":"6","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"B54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresbull.2014.02.007","article-title":"Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-kappaB) modulation in experimental Huntington\u2019s disease.","volume":"102","author":"Gupta","year":"2014","journal-title":"Brain Res. Bull."},{"key":"B55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12311-016-0762-4","article-title":"Atxn2 knockout and CAG42-Knock-in cerebellum shows similarly dysregulated expression in calcium homeostasis pathway.","volume":"1","author":"Halbach","year":"2017","journal-title":"Cerebellum"},{"key":"B56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/hmg\/ddq436","article-title":"The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2.","volume":"1","author":"Hallen","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/hmg\/dds427","article-title":"Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.","volume":"2","author":"Hansen","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/jpet.116.237388","article-title":"TAK-063 a novel phosphodiesterase 10A inhibitor, protects from striatal neurodegeneration and ameliorates behavioral deficits in the r6\/2 mouse model of Huntingtons disease.","volume":"360","author":"Harada","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1\u03b1 and BDNF gene expression in a mouse model of Huntington\u2019s disease.","volume":"41","author":"Hathorn","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/hmg\/ddh139","article-title":"Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes.","volume":"13","author":"Helmlinger","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease.","volume":"225","author":"Ho","year":"2010","journal-title":"Exp. Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/mds.21632","article-title":"Sodium phenylbutyrate in Huntington\u2019s disease: a dose-finding study.","volume":"22","author":"Hogarth","year":"2007","journal-title":"Mov. Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington\u2019s disease.","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"6878","DOI":"10.1093\/hmg\/ddu410","article-title":"Deactivation of TBP contributes to SCA17 pathogenesis.","volume":"23","author":"Hsu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.celrep.2015.08.060","article-title":"Large polyglutamine repeats cause muscle degeneration in SCA17 mice.","volume":"13","author":"Huang","year":"2015","journal-title":"Cell Rep."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059438","article-title":"Extracts of adipose derived stem cells slows progression in the R6\/2 model of Huntington\u2019s disease.","volume":"4","author":"Im","year":"2013","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.neuron.2016.02.011","article-title":"Cerebellar transcriptome profiles of ATXN1 transgenic mice reveal SCA1 disease progression and protection pathways.","volume":"6","author":"Ingram","year":"2016","journal-title":"Neuron"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","article-title":"Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-\u03baB pathways.","volume":"53","author":"Jang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbi.2014.01.015","article-title":"Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms.","volume":"38","author":"Jang","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","article-title":"Acetylation targets mutant huntingtin to autophagosomes for degradation.","volume":"137","author":"Jeong","year":"2009","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1073\/pnas.1415195112","article-title":"HDAC inhibition imparts beneficial transgenerational effects in Huntington\u2019s disease mice via altered DNA and histone methylation.","volume":"112","author":"Jia","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","article-title":"Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington\u2019s disease.","volume":"46","author":"Jia","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152498","article-title":"The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington\u2019s disease mice.","volume":"11","author":"Jia","year":"2016","journal-title":"PLoS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets.","volume":"18","author":"Jiang","year":"2011","journal-title":"Nat. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/acn3.135","article-title":"Sirtuin 1 activator SRT2104 protects Huntington\u2019s disease mice.","volume":"1","author":"Jiang","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171-82Q mouse model of Huntington\u2019s disease.","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington\u2019s disease.","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","article-title":"Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington\u2019s disease.","volume":"21","author":"Johri","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000327910","article-title":"Truncated peroxisome proliferator-activated receptor-\u03b3coactivator 1\u03b1splice variant is severely altered in Huntington\u2019s disease.","volume":"8","author":"Johri","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbapap.2015.01.012","article-title":"A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation.","volume":"5","author":"Kang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/hmg\/ddw115","article-title":"Allele-specific regulation of mutant Huntingtin by Wig1 a downstream target of p53.","volume":"25","author":"Kim","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/NEN.0b013e3181d6c436","article-title":"Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease.","volume":"69","author":"Klevytska","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1172\/JCI80339","article-title":"Serine 421 regulates mutant huntingtin toxicity and clearance in mice.","volume":"9","author":"Kratter","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B85","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.drudis.2014.03.016","article-title":"Transcriptional dysregulation in Huntington\u2019s disease: a failure of adaptive transcriptional homeostasis.","volume":"19","author":"Kumar","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162788","article-title":"MiR-196a ameliorates cytotoxicity and cellular phenotype in transgenic Huntington\u2019s disease monkey neural cells.","volume":"11","author":"Kunkanjanawan","year":"2016","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.4161\/auto.21862","article-title":"PPARGC1A\/PGC-1alpha, TFEB and enhanced proteostasis in Huntington disease: defining regulatory linkages between energy production and protein-organelle quality control.","volume":"8","author":"La Spada","year":"2012","journal-title":"Autophagy"},{"key":"B88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.12.008","article-title":"The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington\u2019s disease and in striatal tissue from Huntington\u2019s disease patients.","volume":"267","author":"Laprairie","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1111\/ejn.13275","article-title":"Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington\u2019s disease in vitro model.","volume":"44","author":"Lee","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2016.03.005","article-title":"Safety and efficacy of valproic acid treatment in SCA3\/MJD patients.","volume":"26","author":"Lei","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B91","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.nbd.2012.11.016","article-title":"Phosphodiesterase 10A (PDE10A) localization in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"52","author":"Leuti","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1.","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2016.03.027","article-title":"Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.","volume":"1643","author":"Lin","year":"2016","journal-title":"Brain Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijdevneu.2014.07.004","article-title":"Valproic acid attenuates the suppression of acetyl histone H3 and CREB activity in an inducible cell model of Machado\u2013Joseph disease.","volume":"38","author":"Lin","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2000733","article-title":"The Machado\u2013Joseph disease deubiquitinase ataxin-3 regulates the stability and apoptotic function of p53.","volume":"14","author":"Liu","year":"2016","journal-title":"PLoS Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4103\/1673-5374.156978","article-title":"MicroRNA-124 slows down the progression of Huntington\u2019s disease by promoting neurogenesis in the striatum.","volume":"10","author":"Liu","year":"2015","journal-title":"Neural Regen. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1093\/hmg\/ddu343","article-title":"Deficiency of Ube3a in Huntington\u2019s disease mice brain increases aggregate load and accelerates disease pathology.","volume":"23","author":"Maheshwari","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/nsmb1306","article-title":"The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP.","volume":"14","author":"Mantovani","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","article-title":"The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-\u03baB from the synapse to the nucleus.","volume":"19","author":"Marcora","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","article-title":"Expanding the spectrum of genes involved in Huntington disease using a combined clinical and genetic approach.","volume":"73","author":"Mariani","year":"2016","journal-title":"JAMA Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1750-3639.2008.00249.x","article-title":"Analysis of the repressor element-1 silencing transcription factor\/ neuron-restrictive silencer factor occupancy of Non-Neuronal genes in peripheral lymphocytes from patients with Huntington\u2019s disease.","volume":"20","author":"Marullo","year":"2010","journal-title":"Brain Pathol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"21319","DOI":"10.1073\/pnas.1218331110","article-title":"Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes.","volume":"109","author":"McCullough","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B103","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/JHD-130066","article-title":"Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington\u2019s disease.","volume":"3","author":"McFarland","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tips.2016.12.006","article-title":"Targeting class I histone deacetylases in a \u201dComplex\u201d, environment.","volume":"4","author":"Millard","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mcn.2017.07.004","article-title":"Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington\u2019s disease pathways.","volume":"83","author":"Moily","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"17425","DOI":"10.1523\/JNEUROSCI.3958-11.2011","article-title":"SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA.","volume":"31","author":"Montie","year":"2011","journal-title":"J. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1523\/JNEUROSCI.2006-14.2016","article-title":"Histone deacetylase inhibitors protect against pyruvate dehydrogenase dysfunction in Huntington\u2019s disease.","volume":"10","author":"Naia","year":"2017","journal-title":"J. Neurosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","article-title":"Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington\u2019s disease models.","volume":"54","author":"Naia","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with CBP-Mediated transcription leading to cellular toxicity.","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"B112","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","article-title":"CRE-mediated transcription is increased in Huntington\u2019s disease transgenic mice.","volume":"24","author":"Obrietan","year":"2004","journal-title":"J. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant huntingtin accumulation and Huntington\u2019s disease-associated phenotypes in vivo.","volume":"3","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"key":"B114","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(02)00697-9","article-title":"Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death.","volume":"34","author":"Okazawa","year":"2002","journal-title":"Neuron"},{"key":"B115","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/ddg084","article-title":"PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype.","volume":"12","author":"Okuda","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B116","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","article-title":"SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation.","volume":"2","author":"O\u2019Rourke","year":"2013","journal-title":"Cell Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease.","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"B118","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nbd.2010.01.013","article-title":"Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain CREB, and BDNF.","volume":"38","author":"Puerta","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective.","volume":"281","author":"Qiu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.chembiol.2016.05.015","article-title":"SIRT2- and NRF2-Targeting Thiazole-containing compound with therapeutic activity in Huntington\u2019s disease models.","volume":"23","author":"Quinti","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nrneurol.2011.228","article-title":"Neuronal P\/Q-type calcium channel dysfunction in inherited disorders of the CNS.","volume":"2","author":"Rajakulendran","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1080\/15384101.2015.1033595","article-title":"PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington\u2019s disease (HD).","volume":"14","author":"Ratovitski","year":"2015","journal-title":"Cell Cycle"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014311","article-title":"Transcriptional activation of REST by Sp1 in Huntington\u2019s disease models.","volume":"5","author":"Ravache","year":"2010","journal-title":"PLoS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00018-010-0305-y","article-title":"Downregulation of NF-\u03baB signaling by mutant huntingtin proteins induces oxidative stress and cell death.","volume":"67","author":"Reijonen","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1093\/hmg\/ddr251","article-title":"A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J\/Su(H) in modulating the pathological outcome.","volume":"20","author":"Ren","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B126","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00401-016-1550-4","article-title":"Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.","volume":"132","author":"Rocchi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.nbd.2006.08.002","article-title":"Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington\u2019s disease pathogenesis.","volume":"24","author":"Ryan","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00082","article-title":"Post-translational modifications and protein quality control in motor neuron and polyglutamine diseases.","volume":"10","author":"Sambataro","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuron.2014.12.031","article-title":"Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy.","volume":"1","author":"Scaramuzzino","year":"2015","journal-title":"Neuron"},{"key":"B130","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/nan.12137","article-title":"Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington\u2019s disease neurones.","volume":"40","author":"Schiffer","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination.","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B132","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nbt.3130","article-title":"Acetylation site specificities of lysine deacetylase inhibitors in human cells.","volume":"4","author":"Sch\u00f6lz","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130 interfering with CREB-dependent transcription.","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nat. Genet."},{"key":"B134","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2013.11.015","article-title":"Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation.","volume":"63","author":"Singh","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","article-title":"Altered microRNAs in STHdhQ111\/HdhQ111 cells: MiR-146a targets TBP.","volume":"396","author":"Sinha","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B136","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1523\/JNEUROSCI.0710-11.2011","article-title":"Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.","volume":"31","author":"Sleiman","year":"2011","journal-title":"J. Neurosci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington\u2019s disease.","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B138","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-4159.2010.07122.x","article-title":"Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington\u2019s disease.","volume":"116","author":"Soldati","year":"2011","journal-title":"J. Neurochem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/hmg\/dds177","article-title":"A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset.","volume":"21","author":"Soyal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B140","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"6857","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.nbd.2005.04.018","article-title":"A role for both wild-type and expanded ataxin-7 in transcriptional regulation.","volume":"20","author":"Str\u00f6m","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates Mutant-Huntingtin cytotoxicity.","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"B143","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bcp.12512","article-title":"An exploratory double-blind, randomized clinical trial with selisistat, a Sirtr1 inhibitor, in patients with Huntington\u2019s disease.","volume":"79","author":"S\u00fcssmuth","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.nbd.2012.01.014","article-title":"DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles.","volume":"46","author":"Suzuki","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1242\/dmm.019406","article-title":"Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.","volume":"8","author":"Szlachcic","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00253","article-title":"The generation of mouse and human Huntington disease iPS cells suitable for in vitro studies on huntingtin function.","volume":"10","author":"Szlachcic","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/nsmb.2902","article-title":"Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.","volume":"21","author":"Tan","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B148","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism.","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gad.1087503","article-title":"Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein.","volume":"17","author":"Taylor","year":"2003","journal-title":"Genes Dev."},{"key":"B150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u201cs disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150372","article-title":"Genomic instability associated with p53 knockdown in the generation of Huntington\u2019s disease human induced pluripotent stem cells.","volume":"11","author":"Tidball","year":"2016","journal-title":"PLoS One"},{"key":"B152","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation.","volume":"3","author":"Tr\u00e4ger","year":"2014","journal-title":"Brain"},{"key":"B153","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2015.05.010","article-title":"The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.","volume":"82","author":"Tsou","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington\u2019s disease: a genome-wide perspective.","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(02)00450-3","article-title":"Insoluble TATA-binding protein accumulation in Huntington\u2019s disease cortex.","volume":"109","author":"van Roon-Mom","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1093\/hmg\/ddu081","article-title":"The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.","volume":"14","author":"Venkatraman","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B157","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2017.10.002","article-title":"The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington\u2019s disease protein.","author":"Wang","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.expneurol.2010.05.011","article-title":"Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons.","volume":"224","author":"Wang","year":"2010","journal-title":"Exp. Neurol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12031-012-9739-z","article-title":"Sp1 regulates human huntingtin gene expression.","volume":"47","author":"Wang","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/cns.12795","article-title":"Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.","volume":"24","author":"Wang","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B161","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration.","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-3","article-title":"The gene coding for PGC-1alpha modifies age at onset in Huntington\u2019s disease.","volume":"4","author":"Weydt","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1186\/1471-201377-14-1","article-title":"A single nucleotide polymorphism in the coding region of PGC-1\u03b1 is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.","volume":"14","author":"Weydt","year":"2014","journal-title":"BMC Neurol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease.","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.chembiol.2011.04.012","article-title":"Neuronal Store-Operated calcium entry pathway as a novel therapeutic target for Huntington\u2019s disease treatment.","volume":"18","author":"Wu","year":"2011","journal-title":"Chem. Biol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"35500","DOI":"10.1074\/jbc.M113.479865","article-title":"Lithium down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant huntingtin.","volume":"49","author":"Wu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11839-0","article-title":"Treatment with caffeic acid and resveratrol alleviates oxidative stress induced neurotoxicity in cell and Drosophila models of spinocerebellar ataxia type3.","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"B168","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-Proliferator-Activated receptor gamma coactivator 1 contributes to dysmyelination in experimental models of Huntington\u2019s disease.","volume":"26","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1523\/JNEUROSCI.0111-17.2017","article-title":"Synergistic toxicity of polyglutamine-expanded TATA-binding protein in glia and neuronal cells: therapeutic implications for spinocerebellar ataxia 17.","volume":"38","author":"Yang","year":"2017","journal-title":"J. Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2013.02.012","article-title":"Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington\u2019s disease.","volume":"1504","author":"Yeh","year":"2013","journal-title":"Brain Res."},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054792","article-title":"Sodium valproate alleviates neurodegeneration in SCA3\/MJD via suppressing apoptosis and rescuing the hypoacetylation levels of histone H3 and H4.","volume":"8","author":"Yi","year":"2013","journal-title":"PLoS One"},{"key":"B172","doi-asserted-by":"publisher","first-page":"12580","DOI":"10.1074\/jbc.M511677200","article-title":"Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA.","volume":"281","author":"Ying","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B173","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1385\/JMN:15:1:31","article-title":"Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington\u2019s disease.","volume":"15","author":"Yu","year":"2000","journal-title":"J. Mol. Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.01.029","article-title":"Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels.","volume":"117","author":"Yu-Taeger","year":"2017","journal-title":"Neuropharmacology"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of Huntingtin-Mediated transcriptional repression reveals multiple transcription factor targets.","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"B176","doi-asserted-by":"crossref","first-page":"12935","DOI":"10.1128\/JVI.01952-13","article-title":"Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-\u03baB activation by interacting with p65\/RelA and p50\/NF-\u03baB1.","volume":"87","author":"Zhang","year":"2013","journal-title":"J. Virol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.stemcr.2016.08.018","article-title":"ESC-derived BDNF-overexpressing neural progenitors differentially promote recovery in Huntington\u2019s disease models by enhanced striatal differentiation.","volume":"7","author":"Zimmermann","year":"2016","journal-title":"Stem Cell Rep."},{"key":"B178","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington\u2019s disease.","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases.","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes.","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnmol.2018.00153\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T04:17:41Z","timestamp":1526357861000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnmol.2018.00153\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":180,"alternative-id":["10.3389\/fnmol.2018.00153"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2018.00153","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"article-number":"153"}}